# Flu Vaccine Response in Patients on Biologic Therapies

> **NCT03277703** · PHASE2 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 30 (actual)

## Conditions studied

- Rheumatologic Disorder
- Inflammatory Bowel Diseases
- Immune Complex Diseases

## Interventions

- **BIOLOGICAL:** Influenza vaccine

## Key facts

- **NCT ID:** NCT03277703
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-03
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03277703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03277703, "Flu Vaccine Response in Patients on Biologic Therapies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03277703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*